NanJing Pharmaceutical Company Limited (600713.SS) SHH
5.08
-0.04(-0.78%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 7.11B |
| Enterprise Value | 9.62B |
| P/E Ratio | 10.48 |
| PEG Ratio | 2.41 |
| Price/Sales Ratio | 0.12 |
| Price/Book Ratio | 0.89 |
| Enterprise/Revenue | 0.25 |
| Enterprise/EBITDA | 8.12 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.01 |
| Operating Margin | 0.02 |
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.09 |
Income Statement
| Revenue | 54.96B |
| Revenue/Share | 42.51 |
| Gross Profit | 3.38B |
| EBITDA | 1.74B |
| Net Income | 624.83M |
| Diluted EPS | 0.43 |
Balance Sheet
| Total Cash | 2.22B |
| Total Cash/Share | 1.73 |
| Total Debt | 9.26B |
| Total Debt/Equity | 1.26 |
| Current Ratio | 1.45 |
| Book Value Per Share | 6.59 |
Price History
| 52-Week Change | -3.05 |
| 52-Week High | 6.65 |
| 52-Week Low | 4.81 |
| Moving Average 50 Days | 5.4 |
| Moving Average 200 Days | 5.28 |
Statistics
| Average Volume | 28M |
| Shares Outstanding | 1.31B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.17 |
| Trailing Annual Dividend Yield | 3.35 |
| Payout Ratio | 0.63 |
| Last Split Factor | 2:1 |
| Last Split Date | July 08, 2011 |
